therapeut index antineoplast drug combin intracellular histamin antagonist l-histidinol protein synthesi inhibitor structur analogu l-histidin chemotherapy-tr mice cytoprotect normal stem cell cytotox cell phenylmethyl phenoxi ethanamine.hcl dppe antagonist microsom nuclear intracellular histamin receptor mediat prolifer modul prostaglandin synthesi dppe cytotox cell vitro cytoprotect gut vivo similar pharmacolog profil histidinol dppe structur resembl histidinol histamin intracellular histamin receptor import action histidinol differenti effect dppe histidinol normal malign cell dppe histidinol host cell effect chemotherapi tumor cell vivo histidinol intracellular histamin receptor isol microsom nuclei affin dppe nevertheless agent potenc intracellular histamin receptor potenc dna protein synthesi cytotox normal mitogen-stimul murin lymphocyt mous human breast cancer cell demonstr histidinol g/kg dppe mg/kg murin bone marrow progenitor doxorubicin fluorouracil dose mg/kg antitumor activ doxorubicin daunorubicin murin model earli cancer postul effect intracellular histamin receptor intracellular histamin mediat dna protein synthesi downward modul growth-inhibitori prostaglandin level antagon intracellular action histamin intracellular histamin receptor dppe histidinol differenti perturb growth/eicosanoid metabol normal malign cell basi new approach 